{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T18:54:00Z","timestamp":1791572040873,"version":"4.3.4"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100016198","name":"Idorsia Pharmaceuticals Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016198","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Comprehensive Psychiatry"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.comppsych.2026.152700","type":"journal-article","created":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T14:37:44Z","timestamp":1777214264000},"page":"152700","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Daridorexant for adults with attention deficit hyperactivity disorder (ADHD) and insomnia disorder: An exploratory study"],"prefix":"10.1016","volume":"148","author":[{"given":"Giacomo","family":"Grassi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Scillitani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinna","family":"Moradei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Cecchelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.comppsych.2026.152700_bb0005","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.jad.2023.07.071","article-title":"The global prevalence of attention deficit hyperactivity disorder in children and adolescents: an umbrella review of meta-analyses","volume":"339","author":"Ayano","year":"2023","journal-title":"J Affect Disord"},{"key":"10.1016\/j.comppsych.2026.152700_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2023.115449","article-title":"Prevalence of attention deficit hyperactivity disorder in adults: umbrella review of evidence generated across the globe","volume":"328","author":"Ayano","year":"2023","journal-title":"Psychiatry Res"},{"issue":"1","key":"10.1016\/j.comppsych.2026.152700_bb0015","doi-asserted-by":"crossref","DOI":"10.1136\/bmjment-2023-300809","article-title":"Prevalence of sleep disorder diagnoses and sleep medication prescriptions in individuals with ADHD across the lifespan: a Swedish nationwide register-based study","volume":"26","author":"Ahlberg","year":"2023","journal-title":"BMJ Ment Health"},{"issue":"13","key":"10.1016\/j.comppsych.2026.152700_bb0020","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1177\/10870547241284477","article-title":"Sleep problems in adults with ADHD: prevalences and their relationship with psychiatric comorbidity","volume":"28","author":"van der Ham","year":"2024","journal-title":"J Atten Disord"},{"key":"10.1016\/j.comppsych.2026.152700_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.euroneuro.2020.07.004","article-title":"Sleep in adults with autism spectrum disorder and attention deficit\/hyperactivity disorder: a systematic review and meta-analysis","volume":"38","author":"Lugo","year":"2020","journal-title":"Eur Neuropsychopharmacol"},{"issue":"5","key":"10.1016\/j.comppsych.2026.152700_bb0030","doi-asserted-by":"crossref","first-page":"747","DOI":"10.5664\/jcsm.5810","article-title":"Sleep characteristics in children with attention deficit hyperactivity disorder: systematic review and meta-analyses","volume":"12","author":"D\u00edaz-Rom\u00e1n","year":"2016","journal-title":"J Clin Sleep Med"},{"key":"10.1016\/j.comppsych.2026.152700_bb0035","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.neubiorev.2018.02.014","article-title":"Sleep in adults with ADHD: systematic review and meta-analysis of subjective and objective studies","volume":"89","author":"D\u00edaz-Rom\u00e1n","year":"2018","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.comppsych.2026.152700_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2022.114447","article-title":"Adult ADHD and sleep disorders: prevalence, severity and predictors of sleep disorders in a sample of Italian psychiatric outpatients","volume":"310","author":"Valsecchi","year":"2022","journal-title":"Psychiatry Res"},{"issue":"6","key":"10.1016\/j.comppsych.2026.152700_bb0045","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1080\/14737175.2024.2353692","article-title":"The management of sleep disturbances in children with attention-deficit\/hyperactivity disorder (ADHD): an update of the literature","volume":"24","author":"Cortese","year":"2024","journal-title":"Expert Rev Neurother"},{"issue":"2","key":"10.1016\/j.comppsych.2026.152700_bb0050","doi-asserted-by":"crossref","first-page":"32","DOI":"10.64719\/pb.4063","article-title":"Ramelteon for insomnia related to attention-deficit\/hyperactivity disorder (ADHD)","volume":"44","author":"Fargason","year":"2011","journal-title":"Psychopharmacol Bull"},{"issue":"1","key":"10.1016\/j.comppsych.2026.152700_bb0055","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s12888-019-2216-2","article-title":"Effects and clinical feasibility of a behavioral treatment for sleep problems in adult attention deficit hyperactivity disorder (ADHD): a pragmatic within-group pilot evaluation","volume":"19","author":"Jernel\u00f6v","year":"2019","journal-title":"BMC Psychiatry"},{"issue":"2","key":"10.1016\/j.comppsych.2026.152700_bb0060","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1080\/07420528.2020.1835943","article-title":"Effects of chronotherapy on circadian rhythm and ADHD symptoms in adults with attention-deficit\/hyperactivity disorder and delayed sleep phase syndrome: a randomized clinical trial","volume":"38","author":"van Andel","year":"2021","journal-title":"Chronobiol Int"},{"issue":"1","key":"10.1016\/j.comppsych.2026.152700_bb0065","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1017\/S0033291720001592","article-title":"Combined impact of ADHD and insomnia symptoms on quality of life, productivity, and health care use in the general population","volume":"52","author":"van Andel","year":"2022","journal-title":"Psychol Med"},{"issue":"13","key":"10.1016\/j.comppsych.2026.152700_bb0070","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1177\/10870547241285160","article-title":"Effects of chronotherapeutic interventions in adults with ADHD and delayed sleep phase syndrome (DSPS) on regulation of appetite and glucose metabolism","volume":"28","author":"van Andel","year":"2024","journal-title":"J Atten Disord"},{"key":"10.1016\/j.comppsych.2026.152700_bb0075","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jpsychires.2017.03.004","article-title":"Correcting delayed circadian phase with bright light therapy predicts improvement in ADHD symptoms: a pilot study","volume":"91","author":"Fargason","year":"2017","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.comppsych.2026.152700_bb0080","series-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2013"},{"key":"10.1016\/j.comppsych.2026.152700_bb0085","series-title":"International classification of sleep disorders","author":"American Academy of Sleep Medicine","year":"2014"},{"issue":"4","key":"10.1016\/j.comppsych.2026.152700_bb0090","doi-asserted-by":"crossref","DOI":"10.1111\/jsr.13604","article-title":"Insomnia disorder: state of the science and challenges for the future","volume":"31","author":"Riemann","year":"2022","journal-title":"J Sleep Res"},{"key":"10.1016\/j.comppsych.2026.152700_bb0095","first-page":"11","article-title":"The orexin system. Basic science and role in sleep pathology","volume":"45","author":"Steiner","year":"2021","journal-title":"Front Neurol Neurosci Basel Karger"},{"issue":"2","key":"10.1016\/j.comppsych.2026.152700_bb0100","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.biopsych.2014.10.003","article-title":"Suvorexant in patients with insomnia: results from two 3-month randomized controlled clinical trials","volume":"79","author":"Herring","year":"2016","journal-title":"Biol Psychiatry"},{"issue":"12","key":"10.1016\/j.comppsych.2026.152700_bb0105","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.18254","article-title":"Comparison of lemborexant with placebo and zolpidem tartrate extended release for the treatment of older adults with insomnia disorder: a phase 3 randomized clinical trial","volume":"2","author":"Rosenberg","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"2","key":"10.1016\/j.comppsych.2026.152700_bb0110","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S1474-4422(21)00436-1","article-title":"Safety and efficacy of daridorexant in patients with insomnia disorder: results from two multicentre, randomised, double-blind, placebo-controlled, phase 3 trials","volume":"21","author":"Mignot","year":"2022","journal-title":"Lancet Neurol"},{"issue":"6","key":"10.1016\/j.comppsych.2026.152700_bb0115","doi-asserted-by":"crossref","DOI":"10.1111\/jsr.14035","article-title":"The European insomnia guideline: an update on the diagnosis and treatment of insomnia 2023","volume":"32","author":"Riemann","year":"2023","journal-title":"J Sleep Res"},{"issue":"3","key":"10.1016\/j.comppsych.2026.152700_bb0120","first-page":"378","article-title":"A preliminary report on the effects of daridorexant in patients with comorbid insomnia and substance use disorders","volume":"18","author":"Di Nicola","year":"2025","journal-title":"Pharm (Basel, Switzerland)"},{"issue":"6","key":"10.1016\/j.comppsych.2026.152700_bb0125","doi-asserted-by":"crossref","DOI":"10.1111\/jsr.14196","article-title":"Early experience with the new DORA daridorexant in patients with insomnia disorder and comorbid mental disturbances: results of a naturalistic study with 3months follow-up","volume":"33","author":"Palagini","year":"2024","journal-title":"J Sleep Res"},{"key":"10.1016\/j.comppsych.2026.152700_bb0130","series-title":"DIVA-5: intervista diagnostica per l\u2019ADHD negli adulti secondo i criteri DSM-5","author":"Kooij","year":"2019"},{"key":"10.1016\/j.comppsych.2026.152700_bb0135","series-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2022"},{"key":"10.1016\/j.comppsych.2026.152700_bb0140","first-page":"e70135","article-title":"The effects of daridorexant on patients with comorbid insomnia disorder and untreated mild obstructive sleep Apnoea: a post hoc subgroup analysis of a phase 3, randomised clinical trial","author":"Lettieri","year":"2025","journal-title":"J Sleep Res"},{"issue":"5","key":"10.1016\/j.comppsych.2026.152700_bb0145","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1097\/ALN.0b013e31816d83e4","article-title":"STOP questionnaire: a tool to screen patients for obstructive sleep apnea","volume":"108","author":"Chung","year":"2008","journal-title":"Anesthesiology"},{"key":"10.1016\/j.comppsych.2026.152700_bb0150","series-title":"Insomnia: psychological assessment and management","author":"Morin","year":"1993"},{"issue":"5","key":"10.1016\/j.comppsych.2026.152700_bb0155","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/sleep\/34.5.601","article-title":"The insomnia severity index: psychometric indicators to detect insomnia cases and evaluate treatment response","volume":"34","author":"Morin","year":"2011","journal-title":"Sleep"},{"issue":"9","key":"10.1016\/j.comppsych.2026.152700_bb0160","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1007\/s10072-016-2620-z","article-title":"Validation study of the Italian version of the insomnia severity index (ISI)","volume":"37","author":"Castronovo","year":"2016","journal-title":"Neurol Sci"},{"issue":"3","key":"10.1016\/j.comppsych.2026.152700_bb0165","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-004183","article-title":"The sleep condition indicator: a clinical screening tool to evaluate insomnia disorder","volume":"4","author":"Espie","year":"2014","journal-title":"BMJ Open"},{"issue":"3","key":"10.1016\/j.comppsych.2026.152700_bb0170","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ijpsycho.2015.08.008","article-title":"Italian validation of the sleep condition indicator: a clinical screening tool to evaluate insomnia disorder according to DSM-5 criteria","volume":"98","author":"Palagini","year":"2015","journal-title":"Int J Psychophysiol"},{"issue":"7","key":"10.1016\/j.comppsych.2026.152700_bb0175","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1093\/sleep\/26.7.902","article-title":"Actigraphy in the assessment of insomnia","volume":"26","author":"Valli\u00e8res","year":"2003","journal-title":"Sleep"},{"issue":"4","key":"10.1016\/j.comppsych.2026.152700_bb0180","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/annweh\/wxaa007","article-title":"Actigraphy-based assessment of sleep parameters","volume":"64","author":"Fekedulegn","year":"2020","journal-title":"Ann Work Expos Health"},{"key":"10.1016\/j.comppsych.2026.152700_bb0185","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3389\/fnagi.2015.00166","article-title":"Measuring sleep quality in older adults: a comparison using subjective and objective methods","volume":"7","author":"Landry","year":"2015","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"10.1016\/j.comppsych.2026.152700_bb0190","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.sleep.2013.08.792","article-title":"The role of actigraphy in the assessment of primary insomnia: a retrospective study","volume":"15","author":"Natale","year":"2014","journal-title":"Sleep Med"},{"issue":"3","key":"10.1016\/j.comppsych.2026.152700_bb0195","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/sleep\/26.3.337","article-title":"Practice parameters for the role of actigraphy in the study of sleep and circadian rhythms: an update for 2002","volume":"26","author":"Littner","year":"2003","journal-title":"Sleep"},{"issue":"10","key":"10.1016\/j.comppsych.2026.152700_bb0200","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsab103","article-title":"Measuring sleep regularity: theoretical properties and practical usage of existing metrics","volume":"44","author":"Fischer","year":"2021","journal-title":"Sleep"},{"key":"10.1016\/j.comppsych.2026.152700_bb0205","series-title":"Barkley adult ADHD rating scale-IV (BAARS-IV)","author":"Barkley","year":"2011"},{"issue":"4","key":"10.1016\/j.comppsych.2026.152700_bb0210","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1037\/a0023961","article-title":"Distinguishing sluggish cognitive tempo from attention deficit\/hyperactivity disorder in adults","volume":"121","author":"Barkley","year":"2012","journal-title":"J Abnorm Psychol"},{"key":"10.1016\/j.comppsych.2026.152700_bb0215","series-title":"BAARS-IV. Barkley adult ADHD rating scale-IV (s. pallanti & l. Salerno, trad.). Hogrefe","author":"Barkley","year":"2017"},{"key":"10.1016\/j.comppsych.2026.152700_bb0220","series-title":"Conners continuous performance test","author":"Conners","year":"2014"},{"issue":"6","key":"10.1016\/j.comppsych.2026.152700_bb0225","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1177\/0734282909360011","article-title":"Test review: C. Keith conners, conners 3rd edition (Toronto, Ontario, Canada: multi-health systems, 2008)","volume":"28","author":"Kao","year":"2010","journal-title":"J Psychoeduc Assess"},{"issue":"6","key":"10.1016\/j.comppsych.2026.152700_bb0230","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1017\/S1092852914000406","article-title":"Reliability and validity of the symptoms of depression questionnaire (SDQ)","volume":"19","author":"Pedrelli","year":"2014","journal-title":"CNS Spectr"},{"issue":"4","key":"10.1016\/j.comppsych.2026.152700_bb0235","first-page":"160","article-title":"A new generation rating scale for depression: reliability and validity of the italian version of symptoms of depression questionnaire (SDQ), an RDoC-oriented depression comprehensive assessment","volume":"23","author":"Salerno","year":"2017","journal-title":"J Psychopathol"},{"issue":"2","key":"10.1016\/j.comppsych.2026.152700_bb0240","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3758\/BF03193146","article-title":"GPower 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences","volume":"39","author":"Faul","year":"2007","journal-title":"Behav Res Methods"},{"issue":"1","key":"10.1016\/j.comppsych.2026.152700_bb0245","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1037\/a0024338","article-title":"Effect size estimates: current use, calculations, and interpretation","volume":"141","author":"Fritz","year":"2012","journal-title":"J Exp Psychol Gen"},{"issue":"1","key":"10.1016\/j.comppsych.2026.152700_bb0250","first-page":"19","article-title":"The need to report effect size estimates revisited: an overview of some recommended measures of effect size","volume":"21","author":"Tomczak","year":"2014","journal-title":"Trends Sport Sci"},{"issue":"3","key":"10.1016\/j.comppsych.2026.152700_bb0255","first-page":"639","volume":"32","author":"Pastore","year":"2005","journal-title":"Giornale Italiano di Psicologia"},{"issue":"4","key":"10.1016\/j.comppsych.2026.152700_bb0260","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/1469-8986.00060","article-title":"A generally robust approach to hypothesis testing in independent and correlated groups designs","volume":"40","author":"Keselman","year":"2003","journal-title":"Psychophysiology"},{"issue":"2","key":"10.1016\/j.comppsych.2026.152700_bb0265","first-page":"65","article-title":"A simple sequentially rejective multiple test procedure","volume":"6","author":"Holm","year":"1979","journal-title":"Scand J Stat"},{"key":"10.1016\/j.comppsych.2026.152700_bb0270","series-title":"Teoria statistica delle classi e calcolo delle probabilit\u00e0","first-page":"3","volume":"8","author":"Bonferroni","year":"1936"},{"issue":"3","key":"10.1016\/j.comppsych.2026.152700_bb0275","doi-asserted-by":"crossref","first-page":"349","DOI":"10.5664\/jcsm.6976","article-title":"The association between insomnia and sleep duration in adults with attention-deficit hyperactivity disorder: results from a general population study","volume":"14","author":"Wynchank","year":"2018","journal-title":"J Clin Sleep Med"},{"key":"10.1016\/j.comppsych.2026.152700_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2021.114349","article-title":"The impact of insomnia disorder on adult attention-deficit\/hyperactivity disorder severity: a six-month follow-up study","volume":"308","author":"Fadeuilhe","year":"2022","journal-title":"Psychiatry Res"},{"issue":"2","key":"10.1016\/j.comppsych.2026.152700_bb0285","doi-asserted-by":"crossref","DOI":"10.1002\/jdn.70014","article-title":"Evaluation of orexin-a, adiponectin and apelin-13 serum levels in children diagnosed with attention deficit hyperactivity disorder","volume":"85","author":"Avunduk","year":"2025","journal-title":"Int J Dev Neurosci"},{"issue":"3","key":"10.1016\/j.comppsych.2026.152700_bb0290","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s10072-018-3692-8","article-title":"Decreased serum orexin a levels in drug-naive children with attention deficit and hyperactivity disorder","volume":"40","author":"Baykal","year":"2019","journal-title":"Neurol Sci"},{"key":"10.1016\/j.comppsych.2026.152700_bb0295","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.jpsychires.2025.10.001","article-title":"Efficacy and safety profiles of FDA-approved dual orexin receptor antagonists in depression: a systematic review of pre-clinical and clinical studies","volume":"191","author":"Vasudeva","year":"2025","journal-title":"J Psychiatr Res"},{"issue":"11","key":"10.1016\/j.comppsych.2026.152700_bb0300","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1002\/eat.24039","article-title":"Efficacy, safety, and tolerability of Nivasorexant in adults with binge-eating disorder: a randomized, phase II proof of concept trial","volume":"56","author":"McElroy","year":"2023","journal-title":"Int J Eat Disord"},{"key":"10.1016\/j.comppsych.2026.152700_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.smrv.2025.102121","article-title":"Estimation of the global prevalence and burden of insomnia: a systematic literature review-based analysis","volume":"82","author":"Benjafield","year":"2025","journal-title":"Sleep Med Rev"}],"container-title":["Comprehensive Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010440X26000398?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010440X26000398?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T13:00:37Z","timestamp":1781010037000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010440X26000398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":61,"alternative-id":["S0010440X26000398"],"URL":"https:\/\/doi.org\/10.1016\/j.comppsych.2026.152700","relation":{},"ISSN":["0010-440X"],"issn-type":[{"value":"0010-440X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Daridorexant for adults with attention deficit hyperactivity disorder (ADHD) and insomnia disorder: An exploratory study","name":"articletitle","label":"Article Title"},{"value":"Comprehensive Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.comppsych.2026.152700","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"152700"}}